Higher CA-125 levels are typically linked with extrauterine tumor spread, advanced disease stages (24, 71), and are indicative of lymph node metastasis and greater myometrial invasion depth (72, 73). This evidence concerns the gene MUC16 and metastatic malignant neoplasm in the lymph nodes.